Cargando…

Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study

Prevention of the metabolic consequences of a chronic energy-dense/high-fat diet (HFD) represents a public health priority. Metformin is a strong candidate to be incorporated in alternative therapeutic approaches. We used a targeted metabolomic approach to assess changes related to the multi-faceted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riera-Borrull, Marta, García-Heredia, Anabel, Fernández-Arroyo, Salvador, Hernández-Aguilera, Anna, Cabré, Noemí, Cuyàs, Elisabet, Luciano-Mateo, Fedra, Camps, Jordi, Menendez, Javier A., Joven, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713233/ https://www.ncbi.nlm.nih.gov/pubmed/29143783 http://dx.doi.org/10.3390/ijms18112263

Ejemplares similares

Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users
por: Luciano-Mateo, Fedra, et al.
Publicado: (2017)

Systemic overexpression of C-C motif chemokine ligand 2 promotes metabolic dysregulation and premature death in mice with accelerated aging
por: Luciano-Mateo, Fedra, et al.
Publicado: (2020)

Chemokine C–C motif ligand 2 overexpression drives tissue-specific metabolic responses in the liver and muscle of mice
por: Luciano-Mateo, Fedra, et al.
Publicado: (2020)

Mitochondrial Dysfunction: A Basic Mechanism in Inflammation-Related Non-Communicable Diseases and Therapeutic Opportunities
por: Hernández-Aguilera, Anna, et al.
Publicado: (2013)

Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients
por: Arenas, Meritxell, et al.
Publicado: (2017)

Metabolite normalization with local radiotherapy following breast tumor resection
por: Arenas, Meritxell, et al.
Publicado: (2018)

Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation
por: Fort-Gallifa, Isabel, et al.
Publicado: (2017)

Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease
por: Hernández-Aguilera, Anna, et al.
Publicado: (2018)

Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
por: Cuyàs, Elisabet, et al.
Publicado: (2018)

Immunohistochemical Analysis of Paraoxonases and Chemokines in Arteries of Patients with Peripheral Artery Disease
por: Hernández-Aguilera, Anna, et al.
Publicado: (2015)

Laparoscopic sleeve gastrectomy alters (1)H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease
por: Cabré, Noemí, et al.
Publicado: (2021)

Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based “starvation” strategies in BRCA1 carriers
por: Cuyàs, Elisabet, et al.
Publicado: (2016)

Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity
por: Cuyàs, Elisabet, et al.
Publicado: (2017)

Ubiquitous Transgenic Overexpression of C-C Chemokine Ligand 2: A Model to Assess the Combined Effect of High Energy Intake and Continuous Low-Grade Inflammation
por: Rodríguez-Gallego, Esther, et al.
Publicado: (2013)

Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2019)

Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
por: Cuyàs, Elisabet, et al.
Publicado: (2015)

Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
por: Cuyàs, Elisabet, et al.
Publicado: (2018)

Activation of the methylation cycle in cells reprogrammed into a stem cell-like state
por: Fernández-Arroyo, Salvador, et al.
Publicado: (2016)

Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome
por: Menendez, Javier A., et al.
Publicado: (2016)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis
por: Cabré, Noemí, et al.
Publicado: (2022)

Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells
por: Verdura, Sara, et al.
Publicado: (2022)

A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study
por: Fernández-Sender, Laura, et al.
Publicado: (2013)

Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
por: Verdura, Sara, et al.
Publicado: (2019)

Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology
por: Cuyàs, Elisabet, et al.
Publicado: (2021)

Circulating levels of MOTS-c in patients with breast cancer treated with metformin
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013)

Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview
por: Castañé, Helena, et al.
Publicado: (2021)

Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet
por: Baiges-Gaya, Gerard, et al.
Publicado: (2022)

Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
por: Tramonti, Angela, et al.
Publicado: (2021)

Oncometabolic Nuclear Reprogramming of Cancer Stemness
por: Menendez, Javier A., et al.
Publicado: (2016)

Gerosuppressant Metformin: less is more
por: Menendez, Javier A., et al.
Publicado: (2011)

One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin
por: Menendez, Javier A., et al.
Publicado: (2013)

Computer-aided discovery of biological activity spectra for anti-aging and anti-cancer olive oil oleuropeins
por: Corominas-Faja, Bruna, et al.
Publicado: (2014)

Metformin and cancer: Quo vadis et cui bono?
por: Menendez, Javier A., et al.
Publicado: (2016)

Stratification of cancer and diabetes based on circulating levels of formate and glucose
por: Pietzke, Matthias, et al.
Publicado: (2019)

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
por: Cuyàs, Elisabet, et al.
Publicado: (2019)

PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
por: Camps, Jordi, et al.
Publicado: (2012)

In silico clinical trials for anti-aging therapies
por: Menendez, Javier A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fkmavn375cfa5mqksc0pl0b62v